Atsuko Mugitani
- Co-authors
- Masayuki HinoTakahisa YamaneKensuke OhtaYasutaka AoyamaKaori MakitaMasahiro ManabeJoji NagasakiErina Sakamoto
- Topics
- Acute Myeloid Leukemia Research (8 papers)Lymphoma Diagnosis and Treatment (8 papers)Viral-associated cancers and disorders (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodBritish Journal of Haematology
- Partner nations
- Japan
In The Last Decade
Atsuko Mugitani
26 papers receiving 212 citations
Peers
Comparison fields: 5 of 50
- Hematology 94
- Oncology 78
- Pathology and Forensic Medicine 54
- Molecular Biology 39
- Genetics 37
Countries citing papers authored by Atsuko Mugitani
This map shows the geographic impact of Atsuko Mugitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Mugitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Mugitani more than expected).
Fields of papers citing papers by Atsuko Mugitani
This network shows the impact of papers produced by Atsuko Mugitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Mugitani. The network helps show where Atsuko Mugitani may publish in the future.
Co-authorship network of co-authors of Atsuko Mugitani
This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Mugitani. A scholar is included among the top collaborators of Atsuko Mugitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Mugitani. Atsuko Mugitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 16 | |
| 7 | 1 | |
| 8 | Chronic myelogenous leukemia after postoperative adjuvant S-1 therapy for rectal cancer: a case report. | 2 |
| 9 | 2 | |
| 10 | 37 | |
| 11 | 49 | |
| 12 | 7 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 2 | |
| 16 | [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange]. | 2 |
| 17 | [VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report]. | 1 |
| 18 | [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]. | 1 |
| 19 | 40 | |
| 20 | Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas. | 6 |
About Atsuko Mugitani
Atsuko Mugitani is a scholar working on Hematology, Applied Microbiology and Biotechnology and Genetics, having authored 28 papers that have together received 219 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Hematology (94 citations), Genetics (37 citations) and Pathology and Forensic Medicine (54 citations). Atsuko Mugitani has collaborated with scholars based in Japan. Frequent co-authors include Masayuki Hino, Takahisa Yamane, Kensuke Ohta, Yasutaka Aoyama, Kaori Makita, Masahiro Manabe, Joji Nagasaki, Erina Sakamoto, Hideo Koh and Hirohisa Nakamae. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.